Cargando…
A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex
Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is a mechanistic target of rapamycin (mTOR) inhibito...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767712/ https://www.ncbi.nlm.nih.gov/pubmed/36561726 http://dx.doi.org/10.1155/2022/2893975 |
_version_ | 1784854018655256576 |
---|---|
author | Yamada, Kaori Yamanishi, Yukio Aratake, Junichi Sasagasako, Nanayo Inayama, Yoshihide Gou, Rei Kawamura, Atsuko Yamanishi, Megumi Kosaka, Kenzo |
author_facet | Yamada, Kaori Yamanishi, Yukio Aratake, Junichi Sasagasako, Nanayo Inayama, Yoshihide Gou, Rei Kawamura, Atsuko Yamanishi, Megumi Kosaka, Kenzo |
author_sort | Yamada, Kaori |
collection | PubMed |
description | Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is a mechanistic target of rapamycin (mTOR) inhibitor. A 42-year-old female patient (gravida 0) with a history of TSC presented with abdominal pain. Pelvic magnetic resonance imaging showed multiple masses in the uterine myometrium, suggesting tumors that may contain internal hemorrhagic components. The lesions were suspected as the root cause of her symptoms. After everolimus was administered for a previously diagnosed renal angiolipoma, her uterine tumors temporarily decreased in size. Subsequently, laparoscopic hysterectomy and bilateral salpingectomy were performed since she could not tolerate everolimus for a long period due to the medication's side effects. Furthermore, the patient was diagnosed with LAM through histopathological examination after surgical resection. Therefore, it is advisable to suspect and investigate uterine LAM when a patient with a history of TSC presents with irregular genital bleeding or abdominal pain. Moreover, mTOR inhibitors may be a treatment option, in addition to surgery, in cases of uterine LAM exacerbation. |
format | Online Article Text |
id | pubmed-9767712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-97677122022-12-21 A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex Yamada, Kaori Yamanishi, Yukio Aratake, Junichi Sasagasako, Nanayo Inayama, Yoshihide Gou, Rei Kawamura, Atsuko Yamanishi, Megumi Kosaka, Kenzo Case Rep Obstet Gynecol Case Report Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is a mechanistic target of rapamycin (mTOR) inhibitor. A 42-year-old female patient (gravida 0) with a history of TSC presented with abdominal pain. Pelvic magnetic resonance imaging showed multiple masses in the uterine myometrium, suggesting tumors that may contain internal hemorrhagic components. The lesions were suspected as the root cause of her symptoms. After everolimus was administered for a previously diagnosed renal angiolipoma, her uterine tumors temporarily decreased in size. Subsequently, laparoscopic hysterectomy and bilateral salpingectomy were performed since she could not tolerate everolimus for a long period due to the medication's side effects. Furthermore, the patient was diagnosed with LAM through histopathological examination after surgical resection. Therefore, it is advisable to suspect and investigate uterine LAM when a patient with a history of TSC presents with irregular genital bleeding or abdominal pain. Moreover, mTOR inhibitors may be a treatment option, in addition to surgery, in cases of uterine LAM exacerbation. Hindawi 2022-12-13 /pmc/articles/PMC9767712/ /pubmed/36561726 http://dx.doi.org/10.1155/2022/2893975 Text en Copyright © 2022 Kaori Yamada et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yamada, Kaori Yamanishi, Yukio Aratake, Junichi Sasagasako, Nanayo Inayama, Yoshihide Gou, Rei Kawamura, Atsuko Yamanishi, Megumi Kosaka, Kenzo A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title | A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title_full | A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title_fullStr | A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title_full_unstemmed | A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title_short | A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex |
title_sort | case of uterine lymphangioleiomyomatosis complicated by tuberous sclerosis complex |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767712/ https://www.ncbi.nlm.nih.gov/pubmed/36561726 http://dx.doi.org/10.1155/2022/2893975 |
work_keys_str_mv | AT yamadakaori acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT yamanishiyukio acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT aratakejunichi acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT sasagasakonanayo acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT inayamayoshihide acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT gourei acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT kawamuraatsuko acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT yamanishimegumi acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT kosakakenzo acaseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT yamadakaori caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT yamanishiyukio caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT aratakejunichi caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT sasagasakonanayo caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT inayamayoshihide caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT gourei caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT kawamuraatsuko caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT yamanishimegumi caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex AT kosakakenzo caseofuterinelymphangioleiomyomatosiscomplicatedbytuberoussclerosiscomplex |